Amplifon S.p.A. (0N61.IL)
| Previous close | 31.86 |
| Open | 31.71 |
| Bid | 31.07 x 0 |
| Ask | 32.66 x 0 |
| Day's range | 31.71 - 31.97 |
| 52-week range | 24.49 - 36.24 |
| Volume | |
| Avg. volume | 34,840 |
| Market cap | 7.408B |
| Beta (5Y monthly) | 0.73 |
| PE ratio (TTM) | 41.39 |
| EPS (TTM) | 0.77 |
| Earnings date | N/A |
| Forward dividend & yield | 0.29 (1.07%) |
| Ex-dividend date | 22 May 2023 |
| 1y target est | N/A |
ZacksAll You Need to Know About Amplifon S.p.A. (AMFPF) Rating Upgrade to Buy
Amplifon S.p.A. (AMFPF) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Business WireAmplifon Recognized as 2024 Top Employer for the First Time in North America and Canada
MISSISSAUGA, Ontario, January 18, 2024--Amplifon, the world leader in hearing care services and solutions, has been confirmed as a global ‘Top Employer’ and received the award for the first time for the North American region thanks to first-time certifications in Canada and Panama, and the repeat confirmation in the United States.
Business WireAmplifon and Miracle-Ear Recognized as 2024 Top Employers in the U.S. and, for the First Time, in North America
MINNEAPOLIS, January 18, 2024--Amplifon, the world leader in hearing care services and solutions, and its subsidiaries, Miracle-Ear and Amplifon Hearing Health Care, have been confirmed as global ‘Top Employers’ in the United States and received certification for the first time for the North American region thanks to first-time certifications in Canada and Panama.
